Author
Oregon Health & Science UniversityORCID 0000-0003-1287-7283Unclaimed ORCID profile · follow to get notified of new preprints
4 papers
Recent·Most cited
Aaron T. Dirck, Nicole L. Diggins, Wilma D. Perez…·Patrizia Caposio
This study shows HCMV uses UL8 and miR-UL36 to suppress Notch signaling, promoting reactivation in CD34+ hematopoietic progenitor cells.
Samuel Medica, Nicole L. Diggins, Michael C. Denton…·Meaghan H. Hancock
This study identifies UL78 as a nuclear-localized GPCR essential for HCMV reactivation from latency in CD34+ HPCs, showing its Gi coupling and interactome involvement in nuclear processes.
Claire E. Otero, Sophia Petkova, Martin Ebermann…·Philipp Kolb
This study identifies and characterizes Rhesus CMV-encoded Fcγ-binding glycoproteins, showing they delay antibody-mediated immune control during primary infection.
Tabitha D. Manuel, Matilda J. Moström, Chelsea M. Crooks…·Amitinder Kaur
The nonhuman primate model mirrors the epidemiology of human congenital CMV (cCMV) after primary infection and reveals its transmission bottlenecks.